Related Experiment Video
Updated: Jun 13, 2026
09:21
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Emergency management of acute ischemic stroke
Neelofer Shafi1, Joshua M Levine
1Department of Neurology, University of Pennsylvania Medical Center, Philadelphia, 19104, USA.
Current Atherosclerosis Reports
|May 11, 2010
Summary
Rapid evaluation is crucial for acute ischemic stroke patients to identify treatment candidates. New therapies, including extended time windows for intravenous recombinant tissue plasminogen activator (IV rtPA) and intra-arterial thrombolysis, offer improved outcomes.
Area of Science:
- Neurology
- Emergency Medicine
- Radiology
Background:
- Expeditious evaluation of acute ischemic stroke is critical due to emerging therapeutic options.
- Initial assessment focuses on symptom onset, deficit severity, and excluding stroke mimics like intracranial hemorrhage.
Purpose of the Study:
- To review the current diagnostic and therapeutic strategies for acute ischemic stroke.
- To highlight the role of advanced imaging and thrombolytic therapies.
Main Methods:
- Review of current clinical guidelines and literature on acute ischemic stroke management.
- Discussion of diagnostic modalities including CT and MRI perfusion studies.
- Analysis of treatment options: intravenous recombinant tissue plasminogen activator (IV rtPA) and intra-arterial thrombolysis.
Main Results:
- CT and MRI perfusion imaging can identify the ischemic penumbra, aiding treatment selection.
- Intravenous rtPA is the standard treatment, with an extended time window to 4.5 hours for eligible patients.
- Intra-arterial thrombolysis is increasingly used as rescue or primary therapy.
Conclusions:
- Timely and accurate patient evaluation is paramount for effective acute ischemic stroke treatment.
- Advanced imaging and evolving thrombolytic strategies, including intra-arterial approaches, are expanding treatment possibilities.
- Ongoing trials are crucial for further defining the role and safety of intra-arterial therapies.
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
01:15Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
01:26Transient Ischemic Attack l: Introduction
A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...